Showing results (51-60 of 82) with videos related to
Sort By:
Pageof 9
Cancer Chemotherapy and Pharmacology|June 6, 2020
Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexateKathleen Dekeister, Pierre-Adrien Bolze, Michel Tod, et al.Current Vascular Pharmacology|June 26, 2012
Effect of low molecular weight heparins and fondaparinux upon thrombin generation triggered by human pancreatic cancer cells BXPC3Grigoris T Gerotziafas, Vassiliki Galea, Elisabeth Mbemba, et al.European Journal of Medical Genetics|November 13, 2020
Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemicPatrick R Benusiglio, Clément Korenbaum, Roseline Vibert, et al.Pharmaceutical Research|July 18, 2020
Pharmacokinetic and Pharmacogenetic Study of Etoposide in High-Dose Protocol (TI-CE) for Advanced Germ Cell TumorsSotheara Moeung, Christine Chevreau, Sabrina Marsili, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2011
Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international databaseAnja Lorch, Caroline Bascoul-Mollevi, Andrew Kramar, et al.Bulletin Du Cancer|January 28, 2009
[Chemotherapy in the elderly: how and for whom?]Danièle Avenin, Frédéric Selle, Joseph Gligorov, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Prognostic factors in patients with metastatic germ cell tumors who experienced treatment failure with cisplatin-based first-line chemotherapy, Anja Lorch, Jörg Beyer, et al.Anticancer Research|July 5, 2020
GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian CancerFrÉdÉric Selle, Pierre-Etienne Heudel, Anne-Claire Hardy-Bessard, et al.European Journal of Cancer (Oxford, England : 1990)|December 25, 2004
High-dose chemotherapy with haematopoietic stem cell transplantation for metastatic breast cancer patients: final results of the French multicentric randomised CMA/PEGASE 04 protocolJean-Pierre Lotz, Hervé Curé, Maud Janvier, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 21, 2017
Therapeutic Drug Monitoring of Carboplatin in High-Dose Protocol (TI-CE) for Advanced Germ Cell Tumors: Pharmacokinetic Results of a Phase II Multicenter StudySotheara Moeung, Christine Chevreau, Sophie Broutin, et al.Pageof 9